| Members |
targetComponentId |
| Capsulectomy of kidney |
Decortication of kidney |
| Capsulotomy of lens with removal of foreign body |
Capsulotomy of lens with removal of foreign body (procedure) |
| Capsulotomy of lens with removal of foreign body |
Surgical removal of foreign body from lens |
| huvudbjudning |
Caput succedaneum |
| huvudbjudning |
Vertex presentation with caput succedaneum (finding) |
| huvudbjudning |
Vertex presentation |
| bedömning av bil |
Driving assessment |
| karbamazepin 200 mg, tablett med modifierad frisättning |
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| karbamazepin 400 mg, tablett med modifierad frisättning |
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Carbamazepine level: [serum] or [blood] |
Serum carbamazepine measurement |
| Carbamazepine level: [serum] or [blood] |
Serum carbamazepine measurement |
| Carbamazepine level: [serum] or [blood] |
Carbamazepine blood measurement |
| Carbamide peroxide otic agent |
Urea hydrogen peroxide |
| Carbamide peroxide otic agent |
Pharmaceutical / biologic product (product) |
| Carbaryl 0.5% alcoholic lotion |
Carbaryl 5 mg/mL cutaneous lotion |
| karbaryl 0,5 %, alkoholhaltig lotion |
Carbaryl 5 mg/mL cutaneous lotion |
| dental borrspets av karbid, engångs |
Carbide dental bur |
| biverkning av kombinationen karbidopa och levodopa |
Adverse reaction to carbidopa and/or levodopa |
| karbocystein 125 mg/5 ml, sirap, för barn |
Product containing precisely carbocisteine 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| karbocystein 250 mg/5 ml, sirap |
Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
| karbomer-980 2 mg/g, ögongel |
Product containing only carbomer-980 in ocular dose form (medicinal product form) |
| karbomer-980 2 mg/g, ögongel för engångsbruk |
Product containing only carbomer-980 in ocular dose form (medicinal product form) |
| koldioxidabsorbent, flergångs |
Carbon dioxide absorber |
| koldioxidabsorbent, engångs |
Carbon dioxide absorber |
| mätning av koldioxid |
Carbon dioxide content measurement |
| mätning av koldioxid |
Measurement of partial pressure of carbon dioxide in blood |
| Carbon tetrachloride |
Carbon tetrachloride |
| Carboplatin 600mg/60mL infusion |
Antineoplastic agent |
| karboprost 250 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Carboprost (as carboprost trometamol) 250 microgram/mL solution for injection |
| karbunkel/böld |
Carbuncle (disorder) |
| karbunkel/böld |
Furuncle (disorder) |
| Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
| Carcinoembryonic antigen: (& level) |
Carcinoembryonic antigen |
| Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
| Carcinoma cervix uteri: [adenocarcinoma] or [invasive] |
Adenocarcinoma of cervix |
| Carcinoma gallbladder |
Primary malignant neoplasm of gallbladder (disorder) |
| Carcinoma gallbladder |
Carcinoma of gallbladder (disorder) |
| Carcinoma gallbladder |
Malignant tumor of gallbladder |
| Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of liver and/or biliary system (disorder) |
| Carcinoma in situ of biliary system (& [and liver]) |
Carcinoma in situ of biliary tract |
| Carcinoma in situ of cervix |
Carcinoma in situ of uterine cervix |
| Carcinoma in situ of cervix |
Cervical intraepithelial neoplasia |
| Carcinoma in situ of cervix |
Cervical smear - severe dyskaryosis |
| Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of digestive organ |
| Carcinoma in situ of digestive sytem: [organs] or [G.I. tract] |
Carcinoma in situ of gastrointestinal tract |
| Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal drainage system (disorder) |
| Carcinoma in situ of lacrimal drainage structure |
Carcinoma in situ of lacrimal gland duct (disorder) |
| Carcinoma in situ of lacrimal duct |
Carcinoma in situ of lacrimal gland duct (disorder) |
| Carcinoma in situ of lacrimal duct |
Carcinoma in situ of nasolacrimal duct (disorder) |
| Carcinoma in situ of lip, oral cavity and pharynx NOS |
Carcinoma in situ of mouth |
| carcinoma in situ i läpp, munhåla och farynx |
Carcinoma in situ of mouth |
| carcinoma in situ i läpp, munhåla och farynx |
Carcinoma in situ of lip |
| carcinoma in situ i läpp, munhåla och farynx |
Carcinoma in situ of pharynx |
| Carcinoma in situ of orbit |
Neoplasm of orbit |
| carcinoma in situ på annat ställe i bröst |
Carcinoma in situ of breast |
| Carcinoma in situ of respiratory system: [other specified parts] or [nasal sinuses] |
Carcinoma in situ of respiratory system |
| carcinoma in situ i hud på ben |
Carcinoma in situ of skin of lower limb |
| carcinoma in situ i hud på ben |
Carcinoma in situ of skin of lower leg |
| carcinoma in situ i huden på underarm |
Carcinoma in situ of skin of forearm |
| carcinoma in situ i hud på nedre extremitet och höft |
Carcinoma in situ of skin of hip |
| carcinoma in situ i hud på nedre extremitet och höft |
Carcinoma in situ of skin of lower limb |
| Carcinoma in situ of skin of lower limb or hip NOS |
Carcinoma in situ of skin of lower limb |
| carcinoma in situ i huden på bålen, med undantag av skrotum |
Carcinoma in situ of skin of trunk |
| carcinoma in situ i hud på övre extremitet och axel |
Carcinoma in situ of skin of shoulder |
| Carcinoma in situ of uterus: [other and unspecified parts] or [body] |
Carcinoma in situ of female genital organ |
| Carcinoma in situ of uterus: [other and unspecified parts] or [body] |
Carcinoma in situ of body of uterus |
| Carcinoma in situ: [lip] or [oral cavity] or [pharynx] |
Carcinoma in situ of mouth |
| karcinom i epididymis/sädessträng |
Carcinoma of epididymis and spermatic cord (disorder) |
| karcinom i epididymis/sädessträng |
Primary malignant neoplasm of spermatic cord (disorder) |
| karcinom i epididymis/sädessträng |
Primary malignant neoplasm of epididymis |
| Carcinoma of esophagus |
Primary malignant neoplasm of esophagus (disorder) |
| Carcinoma of esophagus |
Malignant tumour of oesophagus |
| Carcinoma of esophagus |
Carcinoma of esophagus (disorder) |
| Carcinoma of head of pancreas |
Malignant tumor of head of pancreas |
| Carcinoma of head of pancreas |
Primary malignant neoplasm of head of pancreas (disorder) |
| Carcinoma of head of pancreas |
Carcinoma of head of pancreas |
| karcinom i lungparenkym |
Malignant tumour of lung parenchyma |
| karcinom i mellanlob, bronk eller lunga |
Malignant neoplasm of middle lobe of right lung (disorder) |
| karcinom i mellanlob, bronk eller lunga |
Malignant neoplasm of middle lobe bronchus |
| karcinom i mellanlob, bronk eller lunga |
Primary malignant neoplasm of lung |
| karcinom i mellanlob, bronk eller lunga |
Carcinoma in situ of lung |
| Carcinoma of oesophagus |
Malignant tumour of oesophagus |
| Carcinoma of oesophagus |
Primary malignant neoplasm of esophagus (disorder) |
| Carcinoma of oesophagus |
Carcinoma of esophagus (disorder) |
| Carcinoma of pancreas |
Carcinoma of pancreas (disorder) |
| Carcinoma of pancreas |
Carcinoma of pancreas (disorder) |
| karcinom i andningsvägarna och intratorakalt organ |
Neoplasm of respiratory tract |
| Carcinoma of stomach |
Carcinoma of stomach (disorder) |
| Carcinoma of stomach |
Carcinoma of stomach (disorder) |
| Carcinoma of stomach |
Malignant tumor of stomach |
| Carcinoma of stomach |
Primary malignant neoplasm of stomach (disorder) |
| Carcinoma of stomach |
Primary malignant neoplasm of stomach (disorder) |
| Carcinoma of stomach |
Malignant tumor of stomach |
| karcinom i övre lob, bronk eller lunga |
Carcinoma in situ of upper lobe bronchus and lung |
| Carcinoma of vocal cord |
Carcinoma of vocal cord (disorder) |
| undersökning av hjärtat med användning av Tc-99m-metoxiisobutylisonitril |
Radionuclide imaging of myocardium using technetium (99m-Tc) sestamibi (procedure) |
| Cardiac adrenergic blocking agent |
Product containing beta adrenergic receptor antagonist (product) |
| Cardiac adrenergic blocking agent |
Pharmaceutical / biologic product (product) |
| Cardiac adrenergic blocking product |
Pharmaceutical / biologic product (product) |
| Cardiac adrenergic blocking product |
Product containing beta adrenergic receptor antagonist (product) |
| Cardiac akinesia |
Cardiac akinesia |
FHIR